Department of General Surgery, Glan Clwyd Hospital, Rhyl, Denbighshire, UK.
Department of General Surgery, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
Surg Endosc. 2020 Aug;34(8):3306-3320. doi: 10.1007/s00464-020-07544-1. Epub 2020 Apr 8.
The comparative evidence regarding the outcomes of closure versus non-closure of mesenteric defects in laparoscopic Roux-en-Y gastric bypass (LRYGB) is poorly understood. We aimed to compare the outcomes of closure versus non-closure of mesenteric defects in LRYGB for morbid obesity.
We conducted a search of electronic information sources to identify all comparative studies investigating the outcomes of closure versus non-closure of mesenteric defects in patients undergoing LRYGB for morbid obesity. We used the Cochrane risk of bias tool and the ROBINS-I tool to assess the risk of bias of RCTs and observational studies, respectively. Random or fixed effects modelling was applied as appropriate.
We included 10,031 patients from six observational studies and 2609 patients from two RCTs. Analysis of observational studies showed closure defects resulted in lower risks of internal hernia (OR 0.28, 95% CI 0.15, 0.54) and reoperation for small bowel obstruction (SBO) (OR 0.30, 95% CI 0.10, 0.83); no difference was found between the two groups in terms of SBO not related to internal hernia (OR 1.19, 95% CI 0.47, 2.99), early SBO (OR 0.74, 95% CI 0.04, 14.38), anastomotic leak (OR 0.84, 95% CI 0.45, 1.57), bleeding (OR 1.08, 95% CI 0.62, 1.89), and anastomotic ulcer (OR 2.08, 95% CI 0.62, 6.94). Analysis of RCTs showed closure of defects resulted in lower risks of internal hernia (OR 0.29, 95% CI 0.19,0.45) and reoperation for SBO (OR 0.51, 95% CI 0.38, 0.69) but higher risks of SBO not related to internal hernia (OR 1.90, 95% CI 1.09, 3.34) and early SBO (OR 2.63, 95% CI 1.16, 5.96); no difference was found between the two groups in terms of anastomotic leak (OR 1.95, 95% CI 0.80, 4.72), bleeding (OR 0.67, 95% CI 0.38, 1.17), and anastomotic ulcer (OR 2.08, 95% CI 0.62, 6.94).
Our results suggest that closure of mesenteric defects in LRYGB may be associated with lower risks of internal herniation and reoperation for SBO compared with non-closure of the defects (moderate certainty). The available evidence is inconclusive regarding the risks of SBO not related to internal hernia and early SBO (low certainty). More RCTs are needed to improve the robustness of the available evidence.
关于腹腔镜 Roux-en-Y 胃旁路术(LRYGB)中关闭与不关闭肠系膜缺损的结局比较证据尚不清楚。我们旨在比较肥胖症患者行 LRYGB 时关闭与不关闭肠系膜缺损的结局。
我们对电子信息源进行了检索,以确定所有比较研究,这些研究调查了肥胖症患者行 LRYGB 时关闭与不关闭肠系膜缺损的结局。我们使用 Cochrane 偏倚风险工具和 ROBINS-I 工具分别评估随机对照试验和观察性研究的偏倚风险。根据需要应用随机或固定效应模型。
我们纳入了来自六项观察性研究的 10031 名患者和来自两项随机对照试验的 2609 名患者。观察性研究分析表明,关闭缺损可降低内疝(OR 0.28,95%CI 0.15,0.54)和再次手术治疗小肠梗阻(SBO)(OR 0.30,95%CI 0.10,0.83)的风险;两组之间与内疝无关的 SBO(OR 1.19,95%CI 0.47,2.99)、早期 SBO(OR 0.74,95%CI 0.04,14.38)、吻合口漏(OR 0.84,95%CI 0.45,1.57)、出血(OR 1.08,95%CI 0.62,1.89)和吻合口溃疡(OR 2.08,95%CI 0.62,6.94)的风险无差异。随机对照试验分析表明,关闭缺损可降低内疝(OR 0.29,95%CI 0.19,0.45)和再次手术治疗 SBO(OR 0.51,95%CI 0.38,0.69)的风险,但与内疝无关的 SBO(OR 1.90,95%CI 1.09,3.34)和早期 SBO(OR 2.63,95%CI 1.16,5.96)的风险更高;两组之间吻合口漏(OR 1.95,95%CI 0.80,4.72)、出血(OR 0.67,95%CI 0.38,1.17)和吻合口溃疡(OR 2.08,95%CI 0.62,6.94)的风险无差异。
我们的结果表明,与不关闭缺损相比,LRYGB 中关闭肠系膜缺损可能与较低的内疝和再次手术治疗 SBO 风险相关(中等确定性)。与内疝无关的 SBO 和早期 SBO 的风险的证据尚无定论(低确定性)。需要更多的随机对照试验来提高现有证据的稳健性。